IG market share potential from competitor supply challenges CSL.AX 12m Price Target: A$150.60 Price: A$136.50 Upside: 10.3% 17 August 2026 | 6:40AM AEST Equity Research CSL Ltd. (CSL.AX) Media articles have recently reported that Grifols (Not Covered) has paused its plasma collections in Canada. These articles have also indicated that Health Canada, the regulatory authority on plasma collections in the region, had issued Grifols a formal notice of non-compliance for failure to follow blood regulations. Whil ...